2012•European Urology SupplementsRequires access

305 Does dose-dependent targeting of fibroblast growth factor (FGF) receptor 1 (FGFR1) impact on growth of renal cell carcinoma?

Ilya Tsimafeyeu, Elina Zaveleva, T. Tolkacheva

Open publisher page 1 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Fibroblast growth factor receptor 1, Medicine, Fibroblast growth factor, Fibroblast growth factor 23, Renal cell carcinoma, Cancer research, Fibroblast growth factor receptor, Fibroblast growth factor receptor 3

Back to paper search Browse research topics Original source

305 Does dose-dependent targeting of fibroblast growth factor (FGF) receptor 1 (FGFR1) impact on growth of renal cell carcinoma? — Research Paper | ScholarLens